Results 261 to 270 of about 66,588 (284)

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

Lancet Oncology, The, 2016
Claire L Vale, Sarah Burdett, Noel W Clarke   +2 more
exaly  

Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors

Journal of Clinical Oncology, 2005
Aristotelis Bamias, Efstathios Kastritis, Ioannis Melakopoulos   +2 more
exaly  

Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review

Nature Reviews Endocrinology, 2010
James R Berenson
exaly  

Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management

Endocrine Reviews, 2018
Dennis M Black, Bo Abrahamsen, Mary L Bouxsein   +2 more
exaly  

Bisphosphonates

Reactions Weekly, 2013
openaire   +2 more sources

Emerging therapeutic opportunities for skeletal restoration

Nature Reviews Drug Discovery, 2011
Masanobu Kawai, Sundeep Khosla, Clifford J Rosen   +2 more
exaly  

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline

Journal of Clinical Oncology, 2017
Glenn George Fletcher, Phillip Blanchette, Sonal Gandhi   +2 more
exaly  

Bisphosphonates: Mechanism of Action and Role in Clinical Practice

Mayo Clinic Proceedings, 2008
Sundeep Khosla
exaly  

Bisphosphonate

Monatsschrift Kinderheilkunde, 2000
F. Rauch, E. Sch�nau, F. H. Glorieux
openaire   +1 more source

Adjuvant bisphosphonates—an option with low estrogen?

Nature Reviews Clinical Oncology, 2011
Michael Fx Gnant
exaly